Just Hours after my receiving the JnJ, the warning about possible blood clots stopped it's use.
Had that news came out sooner, I would have had second thoughts about it.
But neither I nor my wife had any negative effects at all.
Today I read:
JnJ: “It’s just kind of one after another negative news about the vaccine.”
The New York Times
High Hopes for Johnson & Johnson's COVID Vaccine Have Fizzled in the U.S.
With only 11.8 million doses administered in the United States — less than 4% of the total — the “one and done” vaccine has fallen flat.
At a food bank in Reno, Nevada, 12 doses of the Johnson & Johnson vaccine were administered Thursday.
Between the small number of doses distributed and the lack of interest in them, public health experts say, the United States missed a critical opportunity to address health disparities with a vaccine that should have been ideal.
The two-dose vaccines have a higher efficacy rate overall — roughly 95% versus 72% for Johnson & Johnson’s — but studies showed that all three were highly effective at preventing hospitalization and death.
Dr. Clay Marsh, West Virginia’s COVID-19 czar, said that the pause and Johnson & Johnson’s later authorization — more than two months after Pfizer’s and Moderna’s — deprived it of a “halo effect.” By the time West Virginia had an ample supply of all three vaccines, he said, “people started to get this concept that maybe there’s something better about being immunized with Pfizer and Moderna.”
Because of a major production mishap that resulted in a two-month shutdown in operations, Johnson & Johnson has essentially been forced to sit out the brunt of the pandemic in the United States